05.05.2013 Views

Bond Elut Plexa™ Solid-phase Extraction Products - Crawford ...

Bond Elut Plexa™ Solid-phase Extraction Products - Crawford ...

Bond Elut Plexa™ Solid-phase Extraction Products - Crawford ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ADVANTAGE NOTE<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa <strong>Solid</strong>-<strong>phase</strong> <strong>Extraction</strong> <strong>Products</strong><br />

Highly reproducible, fast flow rates<br />

Advantage Statement: The <strong>Bond</strong> <strong>Elut</strong> Plexa family of<br />

SPE products delivers consistent fast flow rates and<br />

reproducible results. The absence of fines in the media<br />

means clogging of the cartridges is significantly reduced.<br />

This is important in the high throughput environment,<br />

where SPE must be performed unattended and overnight,<br />

saving valuable analysis time during the day.<br />

Reliability is one of the key parameters when developing<br />

high throughput sample preparation methods. For<br />

solid-<strong>phase</strong> extraction, uniform particles with a narrow<br />

size distribution lead to better flow characteristics for<br />

sample addition and elution. Plexa sorbent particles are<br />

manufactured using proprietary polymerization techniques<br />

to achieve this very narrow distribution of particle sizes<br />

and zero fines, yielding excellent reproducibility from<br />

cartridge-to-cartridge. The absence of particle fines means<br />

that the risk of frit blockage and therefore sample loss<br />

is dramatically reduced — an important prerequisite in<br />

the analysis of biofluids. Proprietary automated fritting<br />

and real-time QC processes also ensure that channels or<br />

voids in the packed sorbent bed are minimized, preventing<br />

breakthrough of analytes due to channeling. All of these<br />

features contribute to reproducible data and improved<br />

method ruggedness. In addition, the polymer architecture<br />

itself enables simple protocols for robust and troublefree<br />

SPE applications. Innovative research, state-of-the<br />

art manufacturing and monitoring within a stringent<br />

quality system has produced the latest generation of high<br />

performance SPE products: <strong>Bond</strong> <strong>Elut</strong> Plexa and Plexa PCX.<br />

Excellent particle integrity<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa shows excellent particle integrity with<br />

no oversized, damaged or fine particles. In contrast, the<br />

alternative polymer shows lots of broken particles and<br />

fines that may cause frit blockage and potential sample<br />

loss (Figure 1). Working with these alternative cartridges<br />

means additional time and work to attend the SPE process.<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa Alternative Polymer<br />

Figure 1. Comparison of particle sizes of non-polar SPE polymers by<br />

imaging analysis.<br />

Narrow particle size distribution<br />

A comparison of the particle size distribution between<br />

alternative products demonstrates nearly the same mean<br />

particle diameter for both, but significant differences in<br />

the shape of distribution (Figure 2). <strong>Bond</strong> <strong>Elut</strong> Plexa has<br />

a Gaussian-type distribution, whereas the alternative<br />

polymer shows a broad distribution with broken and fine<br />

particles. What are the practical results? The consequences<br />

of the broader size distribution are slower flow rate,<br />

greater risk of blocked wells, and decreased precision<br />

(less reproducibility from cartridge-to-cartridge and<br />

well-to-well).<br />

Figure 2. Comparison of particle size distributions of non-polar SPE<br />

sorbents. <strong>Bond</strong> <strong>Elut</strong> Plexa, mean particle size 46 µm . Alternative Polymer,<br />

mean particle size 47 µm.


<strong>Bond</strong> <strong>Elut</strong> Plexa <strong>Solid</strong>-<strong>phase</strong> <strong>Extraction</strong> <strong>Products</strong><br />

<strong>Bond</strong> <strong>Elut</strong> Plexa<br />

Acidic<br />

Method optimized for acids<br />

1. Condition: 500 µL CH 3 OH, followed by 500 µL water<br />

2. Apply 100 µL plasma diluted 1:3 with 1% formic acid<br />

3. Wash: 500 µL 5% CH 3 OH<br />

4. <strong>Elut</strong>e: 500 µL CH 3 OH<br />

Simple protocols<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa, the non-polar polymer, is universally<br />

applicable and the best choice for the extraction of a wide<br />

range of acidic, neutral and basic analytes from different<br />

matrices.<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa PCX<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa PCX is a cation exchanger with mixedmode<br />

sorbent characteristics and therefore suitable for<br />

the extraction and clean-up of weak bases from biofluids.<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa PCX demonstrates the same excellent<br />

distribution and outstanding particle integrity as <strong>Bond</strong><br />

<strong>Elut</strong> Plexa. A highly controlled sulfonation process results<br />

in zero fines for <strong>Bond</strong> <strong>Elut</strong> Plexa PCX. Figure 3 shows the<br />

general protocol for trouble-free SPE applications with<br />

either <strong>Bond</strong> <strong>Elut</strong> Plexa or <strong>Bond</strong> <strong>Elut</strong> Plexa PCX.<br />

Faster flow rates and no clogging<br />

The practical effect of particle integrity on flow rate is<br />

shown in Figure 4. To compare flow rates between Plexa<br />

PCX and another CX polymeric sorbent, 12 wells were<br />

conditioned with 500 µL methanol followed by 500 µL<br />

of water. Plasma, diluted to 1:3 with phosphoric acid,<br />

was then added to every well, and a constant vacuum of<br />

5 in. Hg was applied. The time was recorded, enabling<br />

flow rates to be calculated.<br />

Neutral<br />

Method optimized for bases and neutrals<br />

1. Condition: 500 µL CH 3 OH, followed by<br />

500 µL water<br />

2. Apply 100 µL plasma diluted 1:3 with<br />

2% NH 3<br />

3. Wash: 500 µL 5% CH 3 OH<br />

4. <strong>Elut</strong>e: 500 µL CH 3 OH<br />

Plexa PCX<br />

Basic<br />

Mixed-mode method optimized for bases<br />

1. Condition: 500 µL CH OH, followed by 500 µL water<br />

3<br />

2. Apply 100 µL plasma diluted 1:3 with 2% H PO 3 4<br />

3. Acidic wash: 500 µL aqueous 2% formic acid<br />

4. Neutral Wash: 500 µL CH OH-CH CN (1:1, v/v)<br />

3 3<br />

5. <strong>Elut</strong>e: 500 µL CH OH-CH CN + 5 % NH (28-30%)<br />

3 3 3<br />

Figure 3. General acid/basic screening using <strong>Bond</strong> <strong>Elut</strong> Plexa and Plexa PCX. Indicated volumes are based on <strong>Bond</strong> <strong>Elut</strong> 96 Plexa 10 mg plate.<br />

For SPE cartridges, elution volume should be 1-2 mL, with higher volumes for less polar analytes.<br />

Flow rate (mL/min)<br />

0.8<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

0.1<br />

0<br />

1 2 3 4 5 6 7 8 9 10 11 12<br />

Well Number<br />

Figure 4. Plexa PCX (blue) demonstrates faster and more reproducible<br />

flow rates. Mean flow rate for Plexa PCX = 0.47 mL/min (%RSD = 24%),<br />

alternative CX polymer mean flow rate = 0.27 mL/min (%RSD=38%).<br />

Typical properties<br />

Parameters <strong>Bond</strong> <strong>Elut</strong> Plexa <strong>Bond</strong> <strong>Elut</strong> Plexa PCX<br />

Pore size (nominal) 120 Å 120 Å<br />

Particle size 45 µm 45 µm<br />

Specific surface<br />

area m2 /g<br />

450 m2 /g 450 m2 /g<br />

pH range stability 1-14 1-14<br />

Chemical resistance<br />

(solvents)<br />

Retention capacity<br />

/ Ion exchange<br />

capacity<br />

Broad range of protic<br />

and non-protic polar<br />

and non-polar solvents<br />

10% of sorbent mass*<br />

Broad range of protic<br />

and non-protic polar<br />

and non-polar solvents<br />

Cation exchange<br />

loading of 1.0 mmol/g<br />

(determined by<br />

elemental analysis of<br />

sulfur content)<br />

*highly dependent on matrix type and specific analyte characteristics<br />

These properties are characteristic but do not constitute specifications.<br />

PCX<br />

Other CX Polymer


<strong>Bond</strong> <strong>Elut</strong> Plexa <strong>Solid</strong>-<strong>phase</strong> <strong>Extraction</strong> <strong>Products</strong><br />

Conclusion<br />

Higher bed packing efficiency in an SPE device is achieved<br />

if the sorbent particles have a very narrow size distribution.<br />

This leads to higher performance. SPE sorbents that contain<br />

a large degree of fines will cause blockage of the sample<br />

and lead to a slow, variable flow of solvent and analyte<br />

through the sorbent bed. Thus, assay variability with respect<br />

to recovery rates will increase.<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa sorbent particles are nearly mono-dispersed<br />

in size, resulting in a very homogeneous packing. Therefore,<br />

reproducible results with excellent recoveries and sharp<br />

elution profiles are the standard. <strong>Bond</strong> <strong>Elut</strong> Plexa products<br />

are highly amenable to a high throughput or automated<br />

platforms due to excellent well-to-well and cartridge-tocartridge<br />

flow reproducibility.<br />

Varian, Inc.<br />

www.varianinc.com<br />

North America: 800.926.3000, 925.939.2400<br />

Europe The Netherlands: 31.118.67.1000<br />

Asia Pacific Australia: 613.9560.7133<br />

Latin America Brazil: 55.11.3238.0400<br />

Other sales offices and dealers throughout the world _ check our Web site.<br />

Chromatography • Spectroscopy • Mass Spectrometry • Magnetic Resonance Spectroscopy and Imaging • X-Ray Crystallography • Dissolution • Consumables • Data Systems • Vacuum<br />

<strong>Bond</strong> <strong>Elut</strong> Plexa, Varian, the Varian logo and the Varian Care logo are trademarks or registered trademarks of Varian, Inc. in the U.S. and<br />

other countries. © 2009 Varian, Inc.<br />

SI-1935 04/09 Printed in U.S.A.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!